Suzhou Ribo Life Science’s $40 Million Series E1 Financing Round

Laura Testa Asia & Pacific Legal Chronicle
Tagged:

Kirkland & Ellis advised Suzhou Ribo Life Science Co., Ltd. on the transaction.Suzhou Ribo Life Science Co., Ltd. (Ribo), a clinical stage company developing innovative RNAi…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Laura Testa

Author: Laura Testa

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here